BE884722A - Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques - Google Patents
Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiquesInfo
- Publication number
- BE884722A BE884722A BE2/58700A BE2058700A BE884722A BE 884722 A BE884722 A BE 884722A BE 2/58700 A BE2/58700 A BE 2/58700A BE 2058700 A BE2058700 A BE 2058700A BE 884722 A BE884722 A BE 884722A
- Authority
- BE
- Belgium
- Prior art keywords
- trihydroxypropane
- therapeutic applications
- mixed ester
- obtaining same
- novel symmetric
- Prior art date
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 title 2
- 235000011187 glycerol Nutrition 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES488665A ES8101585A1 (es) | 1980-02-15 | 1980-02-15 | Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE884722A true BE884722A (fr) | 1980-12-01 |
Family
ID=8479833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE2/58700A BE884722A (fr) | 1980-02-15 | 1980-08-12 | Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE884722A (fr) |
| ES (1) | ES8101585A1 (fr) |
| FR (1) | FR2476095A1 (fr) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| US7030106B2 (en) | 2001-01-26 | 2006-04-18 | Schering Corporation | Sterol absorption inhibitor compositions |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| US7132415B2 (en) | 2001-09-21 | 2006-11-07 | Schering Corporation | Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| US7192944B2 (en) | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7208486B2 (en) | 2003-03-07 | 2007-04-24 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7235543B2 (en) | 2003-03-07 | 2007-06-26 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7417039B2 (en) | 2001-01-26 | 2008-08-26 | Schering Corporation | Use of substituted azetidinone compounds for the treatment of sitosterolemia |
| WO2008112166A2 (fr) | 2007-03-09 | 2008-09-18 | Indigene Pharmaceuticals Inc. | Combinaison de metformine r-(+) lipoate et d'agents antihyperlipidémiques pour le traitement de l'hyperglycémie diabétique et de complications diabétiques |
| US7560449B2 (en) | 2002-11-06 | 2009-07-14 | Schering Corporation | Methods and therapeutic combinations for the treatment of demyelination |
| WO2020243590A1 (fr) | 2019-05-30 | 2020-12-03 | Intercept Pharmaceuticals, Inc. | Compositions pharmaceutiques comprenant un agoniste de fxr et un fibrate pour une utilisation dans le traitement d'une maladie hépatique cholestatique |
| US11311557B2 (en) | 2015-02-06 | 2022-04-26 | Intercept Pharmaceuticals, Inc. | Pharmaceutical compositions for combination therapy |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2692262B1 (fr) * | 1992-06-10 | 1994-08-05 | Adir | Nouveaux nicotinates de diacylglycerols, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1980
- 1980-02-15 ES ES488665A patent/ES8101585A1/es not_active Expired
- 1980-08-01 FR FR8017235A patent/FR2476095A1/fr active Granted
- 1980-08-12 BE BE2/58700A patent/BE884722A/fr not_active IP Right Cessation
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| US7030106B2 (en) | 2001-01-26 | 2006-04-18 | Schering Corporation | Sterol absorption inhibitor compositions |
| US7612058B2 (en) | 2001-01-26 | 2009-11-03 | Schering Corporation | Methods for inhibiting sterol absorption |
| US7417039B2 (en) | 2001-01-26 | 2008-08-26 | Schering Corporation | Use of substituted azetidinone compounds for the treatment of sitosterolemia |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| US7132415B2 (en) | 2001-09-21 | 2006-11-07 | Schering Corporation | Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7560449B2 (en) | 2002-11-06 | 2009-07-14 | Schering Corporation | Methods and therapeutic combinations for the treatment of demyelination |
| US7368563B2 (en) | 2003-03-07 | 2008-05-06 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7192944B2 (en) | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7378518B2 (en) | 2003-03-07 | 2008-05-27 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7368562B2 (en) | 2003-03-07 | 2008-05-06 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7235543B2 (en) | 2003-03-07 | 2007-06-26 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7208486B2 (en) | 2003-03-07 | 2007-04-24 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7732413B2 (en) | 2003-03-07 | 2010-06-08 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| US7741289B2 (en) | 2003-03-07 | 2010-06-22 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| WO2008112166A2 (fr) | 2007-03-09 | 2008-09-18 | Indigene Pharmaceuticals Inc. | Combinaison de metformine r-(+) lipoate et d'agents antihyperlipidémiques pour le traitement de l'hyperglycémie diabétique et de complications diabétiques |
| US11311557B2 (en) | 2015-02-06 | 2022-04-26 | Intercept Pharmaceuticals, Inc. | Pharmaceutical compositions for combination therapy |
| EP4035665A1 (fr) | 2015-02-06 | 2022-08-03 | Intercept Pharmaceuticals, Inc. | Compositions pharmaceutiques pour thérapie combinée |
| US12337003B2 (en) | 2015-02-06 | 2025-06-24 | Intercept Pharmaceuticals, Inc. | Pharmaceutical compositions for combination therapy |
| WO2020243590A1 (fr) | 2019-05-30 | 2020-12-03 | Intercept Pharmaceuticals, Inc. | Compositions pharmaceutiques comprenant un agoniste de fxr et un fibrate pour une utilisation dans le traitement d'une maladie hépatique cholestatique |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2476095B1 (fr) | 1984-03-09 |
| FR2476095A1 (en) | 1981-08-21 |
| ES488665A0 (es) | 1980-12-16 |
| ES8101585A1 (es) | 1980-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2581323B1 (fr) | Nouvelle composition tensio-active, son procede d'obtention et ses applications | |
| FR2556210B1 (fr) | Prothese veineuse et son procede d'obtention | |
| BE884722A (fr) | Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques | |
| RO83549A (fr) | Suspension stable de polymeres hydrosolubles et procede d'obtention | |
| BE886862A (fr) | Dispositifs biomedicaux de separation et procede d'obtention | |
| BE850855A (fr) | Procede de preparation d'homopolymeres et copolymeres d'alpha-mono-olefines | |
| LU79162A1 (fr) | Benzylimidazole derivatives-herbicides et procede d'obtention | |
| BE888578A (fr) | Composition de sec-butylbiphenyle et procede d'obtention, | |
| BE889604A (fr) | Procede de preparation d'acetaldehyde et d'ethanol | |
| FR2529879B1 (fr) | Procede d'expansion de la perlite et produit obtenu | |
| BE858298A (fr) | Composition d'assouplissage d'etoffes et son procede de preparation | |
| FR2510604B1 (fr) | Production d'activateur de plasminogene | |
| RO82681A (fr) | Composition en base de polymere hydrosoluble et procede d'obtention | |
| LU79426A1 (fr) | Compositions purifiees d'urokinase et procede pour leur obtention | |
| BE891532A (fr) | Procede de preparation d'ethyleneglycol et de ses ethers, et produits ainsi obtenus | |
| BE853739A (fr) | Composition d'amino-alcools et leur procede de preparation | |
| BE873008A (fr) | Procede de preparation de polymeres contenant de l'hexacarbonyl-tungstene et polymeres ainsi obtenus | |
| BE890629A (fr) | Procede de preparation d'acetaldehyde | |
| FR2474052B1 (fr) | Nouvelle collagenase, procede d'obtention et applications | |
| BE890630A (fr) | Procede de preparation d'acetaldehyde | |
| BE871536A (fr) | Masse d'enduction et son procede de preparation | |
| FR2601955B1 (fr) | Procede de preparation d'alkyl et d'arylchlorosilane | |
| RO80055A2 (fr) | Composition medicamenteuse antiacneique,antiseboreique et antiactinique et procede d'obtention | |
| FR2559492B1 (fr) | Mousses de matieres polymeriques et leur procede d'obtention | |
| PT67027A (fr) | Procede et installation pour la preparation d'engrais |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: SOCIEDAD ESPANOLA DE ESPECIALIDADES FARMACO-TERAP Effective date: 19940831 |